September 24, 2019
On September 23, 2019, Sandoz, Inc. announced issued a voluntary recall of Ranitidine 150mg capsules, and 300mg capsules due to an elevated amount of an unexpected impurity (NDMA) found in the active pharmaceutical ingredient.
Product Name |
NDC Number |
Lot Nbr. |
Expiration Date |
Date of Manufacture |
RANITIDINE 150mg Capsules 500 count |
0781-2855-05 |
HD1862 |
4/30/2020 |
4/19/2017 |
RANITIDINE 150mg Capsules 500 count |
0781-2855-05 |
HP9438 |
9/30/2020 |
9/5/2017 |
RANITIDINE 150mg Capsules 500 count |
0781-2855-05 |
HP9439 |
9/30/2020 |
9/6/2017 |
RANITIDINE 150mg Capsules 500 count |
0781-2855-05 |
HP9440 |
9/30/2020 |
9/5/2017 |
RANITIDINE 150mg Capsules 60 count |
0781-2855-60 |
HC9266 |
4/30/2020 |
4/19/2017 |
RANITIDINE 150mg Capsules 60 count |
0781-2855-60 |
HD1865 |
4/30/2020 |
4/19/2017 |
RANITIDINE 150mg Capsules 60 count |
0781-2855-60 |
HP9441 |
9/30/2020 |
9/6/2017 |
RANITIDINE 150mg Capsules 60 count |
0781-2855-60 |
JK7994 |
8/31/2021 |
8/7/2018 |
RANITIDINE 150mg Capsules 60 count |
0781-2855-60 |
JK8659 |
8/31/2021 |
8/7/2018 |
RANITIDINE 300mg Capsules 30 count |
0781-2865-31 |
HD8625 |
4/30/2020 |
4/27/2017 |
RANITIDINE 300mg Capsules 30 count |
0781-2865-31 |
HD9275 |
4/30/2020 |
4/27/2017 |
RANITIDINE 300mg Capsules 30 count |
0781-2865-31 |
HU2207 |
8/31/2020 |
8/24/2017 |
RANITIDINE 300mg Capsules 30 count |
0781-2865-31 |
HX6676 |
3/31/2021 |
3/20/2018 |
RANITIDINE 300mg Capsules 30 count |
0781-2865-31 |
HX6677 |
3/31/2021 |
3/20/2018 |
Additional information is available on the FDA's website:
Last updated: March 13, 2020